Real-World Evidence and Johnson & Johnson: NESTcc Unlocking Doors to Medical Device Innovation and Collaboration

ARTICLE SUMMARY:

NESTcc Test-Case company Johnson & Johnson has nearly completed a proactive post-market surveillance for safety and effectiveness of Class II lumbar interbody system device procedures. Real-World Evidence gathered from this and other Test-Cases promises to open the door to new opportunities for device stakeholders to work together to share and leverage powerful real-world data—and shift the paradigm for how medtech innovates.

Real-world data (RWD) and real-world evidence (RWE) aren’t new concepts, but with the rapid uptake of digital health technology and clinical data that is routinely collected from advanced medical devices, a whole new world of opportunity is coming into play. High-quality, “real-world” information is becoming more accessible and is being used by stakeholders including regulators, providers, payors, device manufacturers, and patients, to bring forward technologies that improve health. And, there is even the opportunity to substitute reliable RWE in place of mandatory, expensive, large-scale trials which, considering the continuously evolving nature of medtech, may be more sustainable over time.

This article is restricted to subscribers only.

To continue reading, select one of the options below:

Existing Subscriber?

Sign In to continue reading.


Need Multi-User Access?

Gain access for your entire organization.

Get Quote Check to see if your company already has access

Subscribe to Market Pathways:

Actionable intelligence exploring the people, challenges, and opportunities impacting the global medtech community.

Subscribe to Market Pathways
Subscribe to ELITE Strategist

Become an ELITE Strategist and unlock access to both MedTech Strategist and MTS Market Pathways.

Subscribe to Elite

Questions?

We're here to help! Please contact us at: